Morphic Holding Inc

Morphic Holding, Inc. operates as a holding company. The Company, through its subsidiaries, develops oral integrin drugs for patients suffering from serious chronic diseases, including autoimmune, cardiovascular and metabolic diseases, as well as fibrosis and cancer. Morphic Holding serves customers in the State of Massachusetts.